Smith, Jed W.Barlas, RaphaeMamas, Mamas ABoekholdt, S MatthijsMallat , ZiadLuben, Robert N.Wareham, Nicholas J.Khaw, Kay-TeeMyint, Phyo Kyaw2022-07-292022-07-292021-11-30Smith, J W, Barlas, R, Mamas, M A, Boekholdt, S M, Mallat , Z, Luben, R N, Wareham, N J, Khaw, K-T & Myint, P K 2021, 'Association between serum secretory phospholipase A2 and risk of ischemic stroke', European Journal of Neurology, vol. 28, no. 11, pp. 3650-3655. https://doi.org/10.1111/ene.150041351-5101ORCID: /0000-0003-3852-6158/work/163198889https://hdl.handle.net/2164/18967Acknowledgements and Funding The EPIC-Norfolk study (DOI 10.22025/2019.10.105.00004) has received funding from the Medical Research Council (MR/N003284/1 and MC-UU_12015/1) and Cancer Research UK (C864/A14136). We are grateful to all the participants who have been part of the project and to the many members of the study teams at the University of Cambridge who have enabled this research.7202184engSDG 3 - Good Health and Well-beingIschemic strokepredictionsecretory phospholipase A2 (sPLA2)R MedicineMedical Research Council (MRC)MR/N003284/1MC-UU_12015/1Cancer Research UKC864/A14136RAssociation between serum secretory phospholipase A2 and risk of ischemic strokeJournal article10.1111/ene.150042811